Shenzhen Hepalink Pharmaceutical Group Co., Ltd. at its Annual General Meeting held on 22 May 2023 approved cash dividend of CNY 1.00000000 per 10 shares (tax included) for 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.01 CNY | +1.62% | -1.18% | -14.66% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.66% | 1.82B | |
+16.40% | 42.95B | |
+16.32% | 21.38B | |
+19.70% | 15.05B | |
+18.64% | 14.45B | |
+53.58% | 13.04B | |
-0.05% | 6.79B | |
-12.64% | 6.72B | |
-8.87% | 5.73B | |
+11.21% | 5.47B |
- Stock Market
- Equities
- 002399 Stock
- News Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
- Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Approves Cash Dividend for 2022